Literature DB >> 8107202

Borna disease virus (BDV), a nonsegmented RNA virus, replicates in the nuclei of infected cells where infectious BDV ribonucleoproteins are present.

B Cubitt1, J C de la Torre.   

Abstract

Borna disease virus (BDV) causes neurological disease in a wide range of animal species, providing an important model for studies of persistent viral infection of the central nervous system. In addition, the detection of antibodies that react with BDV antigen in serum from psychiatric patients suggests a role for BDV, or related viruses, in human mental disorders, providing further reason for study of this poorly characterized neurotropic virus. We present evidence that BDV has a nonsegmented negative single-strand RNA genome with the property that viral replication and transcription take place in the nuclei of infected cells where infectious BDV ribonucleoproteins are present. Our results support the view that BDV has unique biological features among animal viruses. Furthermore, the finding that BDV ribonucleoproteins are able to infect susceptible cells raises interesting questions regarding the mechanisms by which some neurotropic viruses may spread through the central nervous system of the infected host without requiring the production of mature infectious virus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8107202      PMCID: PMC236591     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Molecular characterization of the Borna disease agent.

Authors:  J C de la Torre; K M Carbone; W I Lipkin
Journal:  Virology       Date:  1990-12       Impact factor: 3.616

2.  Human infections with Borna disease virus: seroprevalence in patients with chronic diseases and healthy individuals.

Authors:  L Bode; S Riegel; W Lange; H Ludwig
Journal:  J Med Virol       Date:  1992-04       Impact factor: 2.327

3.  A borna virus cDNA encoding a protein recognized by antibodies in humans with behavioral diseases.

Authors:  S VandeWoude; J A Richt; M C Zink; R Rott; O Narayan; J E Clements
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

Review 4.  Borna disease, a possible hazard for man?

Authors:  R Rott; S Herzog; K Bechter; K Frese
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

Review 5.  Infection with Borna disease virus: molecular and immunobiological characterization of the agent.

Authors:  J A Richt; S VandeWoude; M C Zink; J E Clements; S Herzog; L Stitz; R Rott; O Narayan
Journal:  Clin Infect Dis       Date:  1992-06       Impact factor: 9.079

6.  Pharmacological characterization of the glutamate receptor in cultured astrocytes.

Authors:  K H Backus; H Kettenmann; M Schachner
Journal:  J Neurosci Res       Date:  1989-03       Impact factor: 4.164

7.  Preliminary studies on the biology of Borna disease virus.

Authors:  C S Duchala; K M Carbone; O Narayan
Journal:  J Gen Virol       Date:  1989-12       Impact factor: 3.891

8.  Borna disease: association with a maturation defect in the cellular immune response.

Authors:  K M Carbone; S W Park; S A Rubin; R W Waltrip; G B Vogelsang
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

9.  The 24K protein of Borna disease virus.

Authors:  J Thierer; H Riehle; O Grebenstein; T Binz; S Herzog; N Thiedemann; L Stitz; R Rott; F Lottspeich; H Niemann
Journal:  J Gen Virol       Date:  1992-02       Impact factor: 3.891

10.  Analysis of Borna disease virus-specific RNAs in infected cells and tissues.

Authors:  J A Richt; S Vande Woude; M C Zink; O Narayan; J E Clements
Journal:  J Gen Virol       Date:  1991-09       Impact factor: 3.891

View more
  54 in total

1.  Expression and characterization of the Borna disease virus polymerase.

Authors:  M P Walker; I Jordan; T Briese; N Fischer; W I Lipkin
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  RING finger Z protein of lymphocytic choriomeningitis virus (LCMV) inhibits transcription and RNA replication of an LCMV S-segment minigenome.

Authors:  T I Cornu; J C de la Torre
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

3.  Analysis of borna disease virus trafficking in live infected cells by using a virus encoding a tetracysteine-tagged p protein.

Authors:  Caroline M Charlier; Yuan-Ju Wu; Sophie Allart; Cécile E Malnou; Martin Schwemmle; Daniel Gonzalez-Dunia
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

4.  Characterization of the P protein-binding domain on the 10-kilodalton protein of Borna disease virus.

Authors:  T H Malik; M Kishi; P K Lai
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

5.  Implication of a cis-acting element in the cytoplasmic accumulation of unspliced Borna disease virus RNAs.

Authors:  P A Schneider; M Schwemmle; W I Lipkin
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

6.  N-terminal domain of Borna disease virus G (p56) protein is sufficient for virus receptor recognition and cell entry.

Authors:  M Perez; M Watanabe; M A Whitt; J C de la Torre
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

Review 7.  Borna disease virus and human disease.

Authors:  K M Carbone
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

8.  Enhanced neurovirulence of borna disease virus variants associated with nucleotide changes in the glycoprotein and L polymerase genes.

Authors:  Yoshii Nishino; Darwyn Kobasa; Steven A Rubin; Mikhail V Pletnikov; Kathryn M Carbone
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

9.  Active borna disease virus polymerase complex requires a distinct nucleoprotein-to-phosphoprotein ratio but no viral X protein.

Authors:  Urs Schneider; Melanie Naegele; Peter Staeheli; Martin Schwemmle
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

10.  Proteomic analysis reveals selective impediment of neuronal remodeling upon Borna disease virus infection.

Authors:  Elsa Suberbielle; Alexandre Stella; Frédéric Pont; Céline Monnet; Emmanuelle Mouton; Lucile Lamouroux; Bernard Monsarrat; Daniel Gonzalez-Dunia
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.